ORY — ORYZON Genomics SA Share News
0.000.00%
Last trade - 00:00- €204.89m
- €196.06m
Spanish stocks - Factors to watch on March 2
Brief: Oryzon FY Net Loss 2.6 Mln Euros
Brief: Oryzon Receives EMA Approval To Initiate A Phase II Study Of Iadademstat
Spanish stocks - Factors to watch on Feb 24
Brief: Oryzon Gets EMA Approval For Phase II Study Of Iadademstat In Thrombocythemia
Brief: Oryzon Announces Appointment Of Rolando Gutierrez-Esteinou, M.D., As Chief Medical Officer For Cns
Spanish stocks - Factors to watch on Feb 2
Brief: Oryzon Receives Japanese Patent Office Grant Decision
Spanish stocks - Factors to watch on Dec 22
Brief: Oryzon Gets Grant Decision In Japan For Iadademstat
Spanish stocks - Factors to watch on Dec 9
Brief: Oryzon Presents Data For Iadademstat Combinations In AML Patients
Corrected: BRIEF-Oryzon Presents Data For Iadademstat Combinations In AML Patients
Spanish stocks - Factors to watch on Nov 10
Brief: Oryzon To Propose Share Capital Increase Of Up To 125 Mln Euros
Spanish stocks - Factors to watch on Nov 7
Brief: Oryzon 9-Month Net Loss At 1.3 Mln Euros
Brief: Oryzon Announces Positive Clinical Data Of Iadademstat At ASH-2025
Spanish stocks - Factors to watch on Oct 20